Does NIVOLUMAB Cause Cholecystitis? 183 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 183 reports of Cholecystitis have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.2% of all adverse event reports for NIVOLUMAB.
183
Reports of Cholecystitis with NIVOLUMAB
0.2%
of all NIVOLUMAB reports
34
Deaths
134
Hospitalizations
How Dangerous Is Cholecystitis From NIVOLUMAB?
Of the 183 reports, 34 (18.6%) resulted in death, 134 (73.2%) required hospitalization, and 18 (9.8%) were considered life-threatening.
Is Cholecystitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 183 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Cholecystitis?
LENVATINIB (309)
SEMAGLUTIDE (293)
PEMBROLIZUMAB (245)
ADALIMUMAB (234)
METHOTREXATE (205)
RITUXIMAB (159)
LENALIDOMIDE (144)
BEVACIZUMAB (131)
CYCLOPHOSPHAMIDE (131)
DEXAMETHASONE (126)
Which NIVOLUMAB Alternatives Have Lower Cholecystitis Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE